Ovarian carcinoma. Predisposing factors, diagnosis, and management
โ Scribed by Equinn W. Munnell
- Book ID
- 101325628
- Publisher
- John Wiley and Sons
- Year
- 1952
- Tongue
- English
- Weight
- 494 KB
- Volume
- 5
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
โฆ Synopsis
1 year end results of 200 patients with ovarian carcinoma seen at the Sloane Hospital for Women (Presbyterian) between 1922 and 1944. The relative 5-year-survival rate for these patients was 30.8 per cent and the absolute rate, 27.5 per cent. T h e histories, operative findings, and pathological material of these 200 cases have been further analyzed to provide material for this succeeding report on possible predisposing factors in this disease and on some clinical aspects 01 diagnosis and management.
๐ SIMILAR VOLUMES
One hundred ten patients with advanced ovarian carcinoma (Stages IIIA, IIIB, and 1V) were evaluated for survival. They received as first treatment one of the following regimens: melphalan (L-PAM) (41 patients), cyclophosphamide plus methotrexate plus 5-fluorouracil (CMF) (16 patients), cyclophospham
## BACKGROUND. Ovarian carcinoma often is called the "silent killer" because the disease usually is not detected until an advanced stage. The authors' goal was to evaluate preoperative symptoms and factors that may contribute to delayed diagnosis for women with ovarian carcinoma. ## METHODS. A